Kenneth Galbraith - Chair & CEO, Director at Zymeworks Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chair & CEO, Director
Stock Symbol
ZYME on Nasdaq
All Insider Reports
All Insider Reports

Kenneth Galbraith - trading volume in the past year for Zymeworks Inc.

Holdings reported by Kenneth Galbraith for Zymeworks Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 200K $2.24M $11.22 Jan 5, 2024 Direct Common Stock
Common Stock 23.8K $267K $11.22 Jan 8, 2024 Direct
Stock Option (Right to Buy) 300K Jan 5, 2024 Direct Common Stock

Transactions reported by Kenneth Galbraith for Zymeworks Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.